scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2012.01.055 |
P698 | PubMed publication ID | 22330127 |
P2093 | author name string | Wei Pan | |
Jie Cao | |||
Zhenyu Zhu | |||
Guangguo Tan | |||
Yifeng Chai | |||
Qiuli Chen | |||
Huaqun Zhang | |||
Wenting Liao | |||
P2860 | cites work | Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV | Q27652984 |
HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region | Q28252310 | ||
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART | Q28476094 | ||
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys | Q33984182 | ||
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication | Q34336210 | ||
Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein | Q35024694 | ||
Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. | Q35585108 | ||
What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? | Q37220038 | ||
Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. | Q37347813 | ||
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate | Q37661107 | ||
The preventive phase I trial with the HIV-1 Tat-based vaccine | Q38378021 | ||
HIV-1 Tat induces biochemical changes in the serum of mice | Q39684517 | ||
Design and characterization of an HIV-1 Tat mutant: inactivation of viral and cellular functions but not antigenicity. | Q40112826 | ||
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters | Q43671904 | ||
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. | Q43692324 | ||
Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers | Q44436413 | ||
Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites | Q44444482 | ||
Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides | Q45572850 | ||
Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA. | Q45722188 | ||
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits | Q46043845 | ||
HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently | Q46346144 | ||
Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants | Q46747253 | ||
HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy | Q46901892 | ||
HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways. | Q51571501 | ||
Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. | Q51828622 | ||
Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo. | Q54739903 | ||
Comparison of the efficacy of early versus late viral proteins in vaccination against SIV | Q56880151 | ||
Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08 | Q57081491 | ||
The therapeutic phase I trial of the recombinant native HIV-1 Tat protein | Q57665211 | ||
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine | Q59511395 | ||
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS | Q61641064 | ||
A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus | Q63343005 | ||
Full-length HIV-1 Tat protein necessary for a vaccine | Q63384219 | ||
Conformational heterogeneity in two regions of TAT results in structural variations of this protein as a function of HIV-1 isolates | Q71514644 | ||
Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor | Q74008668 | ||
HIV-1 Tat suppresses gp120-specific T cell response in IL-10-dependent manner | Q80241849 | ||
Increasing the humoral immunogenic properties of the HIV-1 Tat protein using a ligand-stabilizing strategy | Q81034939 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2453-2461 | |
P577 | publication date | 2012-02-11 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies | |
P478 | volume | 30 |
Q34658608 | Characterization of Tat antibody responses in Chinese individuals infected with HIV-1. |
Q35663722 | Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA. |
Q37419972 | Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency |
Q41468434 | Identification of a highly conserved surface on Tat variants |
Q52608940 | Non-neutralizing Antibody Responses against VP1 in Enterovirus A, B, C and Rhinovirus A species among Infants and Children in Shanghai. |
Search more.